# GW873140 In Combination With Combivir In HIV Infected Subjects

> **NCT00104429** · PHASE2 · TERMINATED · sponsor: **ViiV Healthcare** · enrollment: 125 (—)

## Conditions studied

- Infection, Human Immunodeficiency Virus I
- HIV Infection

## Interventions

- **DRUG:** GW873140
- **DRUG:** Combivir

## Key facts

- **NCT ID:** NCT00104429
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 125 (—)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104429, "GW873140 In Combination With Combivir In HIV Infected Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00104429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*